StockNews.com assumed coverage on shares of Sangamo Therapeutics (NASDAQ:SGMO – Free Report) in a research note issued to investors on Tuesday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. SGMO has been the topic of a number of other research reports. Royal Bank of Canada reissued a sector perform rating and […]
MeiraGTx (NASDAQ:MGTX – Get Free Report) and Sangamo Therapeutics (NASDAQ:SGMO – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, analyst recommendations, institutional ownership, dividends, valuation and profitability. Analyst Recommendations This is a summary of current […]
Vertex pays Editas $100M to use gene editing tech fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.
Sangamo Therapeutics Inc.’s cost cuts didn’t hurt just the roughly 162 U.S. workers who lost their jobs this month. It’s also a blow to Jerry Walter, who’s lost five family
ASH: Editas shares data for mid-stage sickle cell disease asset fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.